Drug firms driven by profit not safety

RECENT scandals involving drug safety suggest companies are motivated more by profit than the welfare of patients.

That subtle shift in motivation is undermining the basic notion of right and wrong. Moral ambivalence might well sum up the current situation.

In 2004 the Food and Drug Administration in the US and Harvard issued a severe warning about the dangers to health of Vioxx, Merck’s arthritic drug.